205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
1.34%
Revenue growth below 50% of MCHP's 10.82%. Michael Burry would check for competitive disadvantage risks.
1.62%
Cost growth less than half of MCHP's 6.26%. David Dodd would verify if cost advantage is structural.
0.45%
Gross profit growth below 50% of MCHP's 15.09%. Michael Burry would check for structural issues.
-0.88%
Margin decline while MCHP shows 3.85% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.36%
Operating expenses growth while MCHP reduces costs. John Neff would investigate differences.
2.13%
Total costs growth while MCHP reduces costs. John Neff would investigate differences.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.38%
EBITDA decline while MCHP shows 144.00% growth. Joel Greenblatt would examine position.
-10.57%
EBITDA margin decline while MCHP shows 120.17% growth. Joel Greenblatt would examine position.
-9.38%
Operating income decline while MCHP shows 132.00% growth. Joel Greenblatt would examine position.
-10.57%
Operating margin decline while MCHP shows 128.88% growth. Joel Greenblatt would examine position.
-47.37%
Other expenses reduction while MCHP shows 29.56% growth. Joel Greenblatt would examine advantage.
-19.27%
Pre-tax income decline while MCHP shows 90.61% growth. Joel Greenblatt would examine position.
-20.33%
Pre-tax margin decline while MCHP shows 91.53% growth. Joel Greenblatt would examine position.
-16.22%
Tax expense reduction while MCHP shows 120.44% growth. Joel Greenblatt would examine advantage.
-20.83%
Net income decline while MCHP shows 87.97% growth. Joel Greenblatt would examine position.
-21.88%
Net margin decline while MCHP shows 89.14% growth. Joel Greenblatt would examine position.
-20.00%
EPS decline while MCHP shows 70.34% growth. Joel Greenblatt would examine position.
-20.00%
Diluted EPS decline while MCHP shows 70.34% growth. Joel Greenblatt would examine position.
-4.76%
Share count reduction while MCHP shows 0.33% change. Joel Greenblatt would examine strategy.
-4.76%
Diluted share reduction while MCHP shows 0.33% change. Joel Greenblatt would examine strategy.